Novo Nordisk has agreed to buy Akero Therapeutics and its drug candidate for metabolic dysfunction-associated steatohepatitis (MASH) for $4.7 billion upfront, shortly after claiming FDA approval to ...
The GlassWorm supply-chain campaign has returned with a new, coordinated attack that targeted hundreds of packages, ...
The Open Agentic AI World According To Nvidia Oracle introduces Project Detroit for fast Java interop with JavaScript and Python HPE adds Blackwell, Rubin systems to Nvidia-backed AI push Vite team ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results